Targeted Normoxemia and Supplemental Oxygen–Free Days in Critically Injured Adults
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.2093 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von David J Douin und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, University of Colorado School of Medicine, Aurora. Hauptthemen laut MEDLINE: Critical Illness, Wounds and Injuries, Oxygen Inhalation Therapy, Oxygen Saturation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Importance Supplemental oxygen is fundamental to caring for critically injured adults but can expose them to excess inspired oxygen.
Objective
To determine the safety and effectiveness of targeting normoxemia in critically ill trauma patients. Design, Setting, and Participants This multicenter, stepped-wedge, cluster randomized clinical trial compared targeted normoxemia (defined as a peripheral oxygen saturation [Sp o 2 ] of 90% to 96%) with usual care among adult trauma patients admitted to an intensive care unit (ICU) at 8 level I trauma centers across the US. These trauma centers were randomized at 3-month intervals when they crossed over from usual care to targeting normoxemia. Eligible patients were enrolled between July 15, 2020, and November 14, 2022. All statistical analyses were performed from April 2023 to November 2024 according to intention-to-treat approach.
Intervention
In the usual care group, supplemental oxygen was determined by treating clinicians. In the targeted normoxemia group, a multimodal educational and informatics intervention encouraged decreasing the supplemental oxygen administered whenever Sp o 2 exceeded 96%. Main Outcomes and Measures The primary outcome was supplemental oxygen–free days (SOFDs), defined as the number of days alive and not receiving supplemental oxygen through day 28. Safety outcomes included hypoxemia (defined as Sp o 2 <88%) during the ICU admission, in-hospital mortality, and adverse events.
Results
A total of 12 487 patients were enrolled (mean [SD] age, 51.7 [21.1] years; 8799 males [70.5%]; mean [SD] Injury Severity Score, 19.6 [12.0]). The proportion of ICU time spent in normoxemia increased from 56.2% in the usual care group to 71.6% in the targeted normoxemia group. Hyperoxemia (defined as Sp o 2 >96%) decreased from 42.4% in the usual care group to 26.7% in the targeted normoxemia group, and hypoxemia was similar between groups (1.1% vs 1.1%). The raw mean (SD) number of SOFDs was 19.6 (10.3) days for the targeted normoxemia group and 17.5 (10.4) days for the usual care group (adjusted mean difference [AMD], 0.32 [95% CI, −0.37 to 1.00] days; P = .30). Among patients not receiving mechanical ventilation at ICU admission, mean SOFDs were greater in the targeted normoxemia group than in the usual care group (22.6 [8.30] days vs 20.6 [8.86] days; AMD, 0.75; 95% CI, 0.00-1.50 days). The mean (SD) time for weaning to room air was 1.6 (3.2) days for the targeted normoxemia group and 2.7 (4.0) days for the usual care group (adjusted hazard ratio [AHR], 1.23; 95% CI, 1.13-1.33 days). In-hospital mortality to day 90 occurred in 563 patients (9.9%) in the targeted normoxemia and 732 patients (10.7%) in the usual care group (AHR, 1.05; 95% CI, 0.83-1.33). No adverse events were reported in either group. Conclusions and Relevance This randomized clinical trial showed that targeting normoxemia did not increase the number of SOFDs but safely reduced supplemental oxygen use among critically ill trauma patients. Trial Registration ClinicalTrials.gov Identifier: NCT04534959
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, University of Colorado School of Medicine, Aurora.
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor.
- Department of Emergency Medicine, University of Colorado School of Medicine, Aurora.
- Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Emergency Medicine, Oregon Health & Science University, Portland.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Douin, D. J., Rice, J. D., Anderson, E. L., Jackson, C. L., Cheng, A. C., Xiao, M., Cwik, J., Beaty, L. E., Wild, J. L., Daya, M. R., Doshi, P. B., Eastham, S. C., Goodman, M. D., Gunn, S. R., Haukoos, J. S., Hudson, J. A., Jansen, J. O., McMullan, J. T., Rizzo, J. A., …, & Strategy to Avoid Excessive Oxygen (SAVE-O2) Investigators (2025). Targeted Normoxemia and Supplemental Oxygen–Free Days in Critically Injured Adults. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.2093
Vancouver
Douin DJ, Rice JD, Anderson EL, Jackson CL, Cheng AC, Xiao M, et al. Targeted Normoxemia and Supplemental Oxygen–Free Days in Critically Injured Adults. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.2093
BibTeX
@article{Douin2025,
author = {Douin, David J and Rice, John D and Anderson, Erin L and Jackson, Conner L and Cheng, Alex C and Xiao, Mengli and Cwik, Jessica and Beaty, Laurel E and Wild, Jessica L and Daya, Mohamud R and Doshi, Pratik B and Eastham, Shannon C and Goodman, Michael D and Gunn, Scott R and Haukoos, Jason S and Hudson, Jessica A and Jansen, Jan O and McMullan, Jason T and Rizzo, Julie A and Schreiber, Martin A and Self, Wesley H and Semler, Matthew W and Steinwand, Aimee and Werner, Nicole and Bebarta, Vikhyat S and Schauer, Steven G and Ginde, Adit A and Strategy to Avoid Excessive Oxygen (SAVE-O2) Investigators, Strategy to Avoid Excessive Oxygen (SAVE-O2) Investigators},
title = {Targeted Normoxemia and Supplemental Oxygen–Free Days in Critically Injured Adults},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.2093}
}
EUVIMED